Evidence map›Paper›PMID 39438964›Full record

ArticleJournal of translational medicine2024

Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

Matteo Pallocca, Ivan Molineris, Enrico Berrino, Benedetta Marcozzi, Martina Betti, Lauretta Levati, Stefania D'Atri, Chiara Menin, Gabriele Madonna, Paola Ghiorzo and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Matteo Pallocca *Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy. matteo.pallocca@cnr.it.
Ivan Molineris *Department of Life Science and System Biology, University of Turin, Via Accademia Albertina 13, 10123, Naples, Italy.
Enrico Berrino *Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Benedetta MarcozziBiostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Martina BettiBiostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Lauretta LevatiLaboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy.
Stefania D'AtriLaboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy.
Chiara MeninImmunology and Oncological Molecular Diagnostics, Oncological Institute, IOV IRCCS UOC, Padua, Italy.
Gabriele MadonnaMelanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy.
Paola GhiorzoGenetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Jenny BulgarelliImmunotherapy, Cell Therapy and Biobank Unit, IRCCS Istituto Romagnolo Per lo Studio dei Tumori (IRST) "Dino Amadori", 47014, Meldola, Italy.
Virgina FerraresiSarcoma and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute-Rome, Rome, Italy.
Tiziana VenesioCandiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Monica RodolfoUnit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
Licia RivoltiniUnit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
Luisa LanfranconeDepartment of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy.
Paolo Antonio AsciertoMelanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy.
Luca MazzarellaDepartment of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy.
Pier Giuseppe PelicciDepartment of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy.
Ruggero De MariaInstitute of General Pathology, Catholic University "Sacro Cuore", Rome, Italy.
Gennaro CilibertoScientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Enzo Medico *Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Giandomenico Russo *Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39438964
PMCPMC11494924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.